JP2000516588A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516588A5
JP2000516588A5 JP1998508452A JP50845298A JP2000516588A5 JP 2000516588 A5 JP2000516588 A5 JP 2000516588A5 JP 1998508452 A JP1998508452 A JP 1998508452A JP 50845298 A JP50845298 A JP 50845298A JP 2000516588 A5 JP2000516588 A5 JP 2000516588A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998508452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000516588A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1997/003888 external-priority patent/WO1998004551A1/en
Publication of JP2000516588A publication Critical patent/JP2000516588A/ja
Publication of JP2000516588A5 publication Critical patent/JP2000516588A5/ja
Ceased legal-status Critical Current

Links

JP10508452A 1996-07-29 1997-07-19 細胞増殖阻害のための置換ビスインドリルマレイミド Ceased JP2000516588A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2207896P 1996-07-29 1996-07-29
US60/022,078 1996-07-29
US4849697P 1997-06-03 1997-06-03
US60/048,496 1997-06-03
PCT/EP1997/003888 WO1998004551A1 (en) 1996-07-29 1997-07-19 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (2)

Publication Number Publication Date
JP2000516588A JP2000516588A (ja) 2000-12-12
JP2000516588A5 true JP2000516588A5 (cg-RX-API-DMAC10.html) 2005-03-10

Family

ID=26695475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10508452A Ceased JP2000516588A (ja) 1996-07-29 1997-07-19 細胞増殖阻害のための置換ビスインドリルマレイミド

Country Status (20)

Country Link
US (1) US6228877B1 (cg-RX-API-DMAC10.html)
EP (1) EP0915870B1 (cg-RX-API-DMAC10.html)
JP (1) JP2000516588A (cg-RX-API-DMAC10.html)
KR (1) KR20000029640A (cg-RX-API-DMAC10.html)
CN (1) CN1077571C (cg-RX-API-DMAC10.html)
AR (1) AR007969A1 (cg-RX-API-DMAC10.html)
AT (1) ATE224889T1 (cg-RX-API-DMAC10.html)
AU (1) AU740011B2 (cg-RX-API-DMAC10.html)
BR (1) BR9711607A (cg-RX-API-DMAC10.html)
CA (1) CA2262089A1 (cg-RX-API-DMAC10.html)
CO (1) CO4900054A1 (cg-RX-API-DMAC10.html)
DE (1) DE69715870T2 (cg-RX-API-DMAC10.html)
DK (1) DK0915870T3 (cg-RX-API-DMAC10.html)
ES (1) ES2183163T3 (cg-RX-API-DMAC10.html)
HR (1) HRP970415A2 (cg-RX-API-DMAC10.html)
MA (1) MA24354A1 (cg-RX-API-DMAC10.html)
PE (1) PE91598A1 (cg-RX-API-DMAC10.html)
PT (1) PT915870E (cg-RX-API-DMAC10.html)
TR (1) TR199900186T2 (cg-RX-API-DMAC10.html)
WO (1) WO1998004551A1 (cg-RX-API-DMAC10.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064279B1 (en) * 1998-03-17 2003-06-25 F.Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
EP1224181B1 (en) * 1999-10-12 2003-12-03 F. Hoffmann-La Roche Ag Substituted pyrroles as antiproliferative agents for the treatment of cancer
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
MXPA04004026A (es) * 2001-10-29 2004-07-08 Nektar Therapeutics Al Corp Conjugados polimericos de inhibidores de la proteina quinasa c.
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
RS51826B (sr) 2005-02-09 2012-02-29 Arqule Inc. Maleimid derivati, farmaceutske kompozicije i postupak lečenja kancera
JP2010513386A (ja) * 2006-12-19 2010-04-30 ノバルティス アーゲー キナーゼ阻害剤としてのインドリルマレイミド誘導体
AU2008268613A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
EP2392574B1 (en) 2007-06-22 2013-12-18 ArQule, Inc. Indolyl pyrrolidines for the treatment of cancer
CA2690799C (en) * 2007-06-22 2015-06-16 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
US20170209488A1 (en) 2014-07-17 2017-07-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CN105777751B (zh) * 2016-04-26 2018-12-11 浙江工业大学 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用
CN107973785B (zh) * 2017-11-27 2019-12-31 浙江工业大学上虞研究院有限公司 一种用于检测银离子的荧光探针及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280738B6 (cs) 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
JPH0539289A (ja) 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
JPH07504673A (ja) 1992-03-20 1995-05-25 ザ・ウエルカム・ファウンデーション・リミテッド 抗ウイルス活性を有するインドール誘導体
DE4217964A1 (de) 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2000501771A5 (cg-RX-API-DMAC10.html)
JP2000501599A5 (cg-RX-API-DMAC10.html)
JP2000501018A5 (cg-RX-API-DMAC10.html)
JP2000505690A5 (cg-RX-API-DMAC10.html)
JP2000501324A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501338A5 (cg-RX-API-DMAC10.html)
JP2000501825A5 (cg-RX-API-DMAC10.html)
JP2000515397A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2000501774A5 (cg-RX-API-DMAC10.html)
JP2000502570A5 (cg-RX-API-DMAC10.html)
JP2001500541A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)
JP2001505352A5 (cg-RX-API-DMAC10.html)
JP2000511953A5 (cg-RX-API-DMAC10.html)
JP2000501744A5 (cg-RX-API-DMAC10.html)
JP2000501229A5 (cg-RX-API-DMAC10.html)
JP2000504171A5 (cg-RX-API-DMAC10.html)
JP2000502316A5 (cg-RX-API-DMAC10.html)
JP2000502714A5 (cg-RX-API-DMAC10.html)
JP2001509278A5 (cg-RX-API-DMAC10.html)